Quest PharmaTech Financials
| QPT Stock | CAD 0.04 0.00 0.00% |
Quest |
Understanding current and past Quest PharmaTech Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Quest PharmaTech's financial statements are interrelated, with each one affecting the others. For example, an increase in Quest PharmaTech's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Quest PharmaTech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Quest PharmaTech. Check Quest PharmaTech's Beneish M Score to see the likelihood of Quest PharmaTech's management manipulating its earnings.
Quest PharmaTech Stock Summary
Quest PharmaTech competes with Precious Metals, Boat Rocker, Canso Select, ISign Media, and Highwood Asset. Quest PharmaTech Inc., a biotechnology company, develops and commercializes antibody based immunotherapeutic products for cancer. The company also owns the Photodynamic therapy technology for oncology and dermatology applications and develops Mab AR 9.6 against truncated O-glycan on MUC16 for targeted cancer therapy applications. QUEST PHARMATECH operates under Biotechnology classification in Canada and is traded on TSX Venture Exchange.| Foreign Associate | USA |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | Canada Stock View All |
| Exchange | TSX Venture Exchange |
| ISIN | CA74836M1068 |
| Business Address | 97 Street NW, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.questpharmatech.com |
| Phone | 780 448 1400 |
| Currency | CAD - Canadian Dollar |
You should never invest in Quest PharmaTech without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Quest Stock, because this is throwing your money away. Analyzing the key information contained in Quest PharmaTech's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Quest PharmaTech Key Financial Ratios
There are many critical financial ratios that Quest PharmaTech's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Quest PharmaTech reports annually and quarterly.| Return On Equity | -0.12 | ||||
| Return On Asset | -0.0197 | ||||
| Number Of Shares Shorted | 709 | ||||
| Beta | 0.15 |
Quest Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Quest PharmaTech's current stock value. Our valuation model uses many indicators to compare Quest PharmaTech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Quest PharmaTech competition to find correlations between indicators driving Quest PharmaTech's intrinsic value. More Info.Quest PharmaTech is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Quest PharmaTech's earnings, one of the primary drivers of an investment's value.Quest PharmaTech Systematic Risk
Quest PharmaTech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Quest PharmaTech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Quest PharmaTech correlated with the market. If Beta is less than 0 Quest PharmaTech generally moves in the opposite direction as compared to the market. If Quest PharmaTech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Quest PharmaTech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Quest PharmaTech is generally in the same direction as the market. If Beta > 1 Quest PharmaTech moves generally in the same direction as, but more than the movement of the benchmark.
Quest PharmaTech December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Quest PharmaTech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Quest PharmaTech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Quest PharmaTech based on widely used predictive technical indicators. In general, we focus on analyzing Quest Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Quest PharmaTech's daily price indicators and compare them against related drivers.
| Downside Deviation | 27.39 | |||
| Information Ratio | 0.0873 | |||
| Maximum Drawdown | 58.33 | |||
| Value At Risk | (25.00) | |||
| Potential Upside | 33.33 |
Additional Tools for Quest Stock Analysis
When running Quest PharmaTech's price analysis, check to measure Quest PharmaTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest PharmaTech is operating at the current time. Most of Quest PharmaTech's value examination focuses on studying past and present price action to predict the probability of Quest PharmaTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest PharmaTech's price. Additionally, you may evaluate how the addition of Quest PharmaTech to your portfolios can decrease your overall portfolio volatility.